中国临床神经外科杂志
中國臨床神經外科雜誌
중국림상신경외과잡지
CHINESE JOURNAL OF CLINICAL NEUROSURGERY
2012年
10期
622-624
,共3页
王涛%刘从国%王翔宇%张光辉
王濤%劉從國%王翔宇%張光輝
왕도%류종국%왕상우%장광휘
高血压脑出血%基底节区%微创钻孔引流术%小骨窗开颅术%疗效
高血壓腦齣血%基底節區%微創鑽孔引流術%小骨窗開顱術%療效
고혈압뇌출혈%기저절구%미창찬공인류술%소골창개로술%료효
Hypertensive intracerebral hemorrhage%Basal Ganglia%Micro-invasive Drainage%Small bone window craniotomy%Curative effect
目的分析比较微创钻孔引流术与小骨窗开颅术治疗高血压基底节区出血的临床效果.方法选择具有手术指征的高血压基底节区出血患者126例,其中出血量<50 ml者67例,≥50 ml者59例.采用微创钻孔引流术治疗64例(出血量<50 ml者39例,≥50 ml者25例),采用小骨窗开颅术治疗62例(出血量<50 ml者28例,≥50 ml者34例);分别比较两种术式的治疗效果.结果①两组总有效率无统计学差异(P>0.05).②血肿量<50 ml 的67患者中,微创钻孔引流术的疗效优于小骨窗开颅术(P<0.05).③血肿量≥50 ml的59患者中,小骨窗开颅术的疗效优于微创钻孔引流术(P<0.05).结论本结果提示,对于高血压基底节区出血,出血量<50 ml的患者宜选择微创钻孔术治疗,而对于出血量≥50 ml的患者则宜选择小骨窗开颅术治疗.
目的分析比較微創鑽孔引流術與小骨窗開顱術治療高血壓基底節區齣血的臨床效果.方法選擇具有手術指徵的高血壓基底節區齣血患者126例,其中齣血量<50 ml者67例,≥50 ml者59例.採用微創鑽孔引流術治療64例(齣血量<50 ml者39例,≥50 ml者25例),採用小骨窗開顱術治療62例(齣血量<50 ml者28例,≥50 ml者34例);分彆比較兩種術式的治療效果.結果①兩組總有效率無統計學差異(P>0.05).②血腫量<50 ml 的67患者中,微創鑽孔引流術的療效優于小骨窗開顱術(P<0.05).③血腫量≥50 ml的59患者中,小骨窗開顱術的療效優于微創鑽孔引流術(P<0.05).結論本結果提示,對于高血壓基底節區齣血,齣血量<50 ml的患者宜選擇微創鑽孔術治療,而對于齣血量≥50 ml的患者則宜選擇小骨窗開顱術治療.
목적분석비교미창찬공인류술여소골창개로술치료고혈압기저절구출혈적림상효과.방법선택구유수술지정적고혈압기저절구출혈환자126례,기중출혈량<50 ml자67례,≥50 ml자59례.채용미창찬공인류술치료64례(출혈량<50 ml자39례,≥50 ml자25례),채용소골창개로술치료62례(출혈량<50 ml자28례,≥50 ml자34례);분별비교량충술식적치료효과.결과①량조총유효솔무통계학차이(P>0.05).②혈종량<50 ml 적67환자중,미창찬공인류술적료효우우소골창개로술(P<0.05).③혈종량≥50 ml적59환자중,소골창개로술적료효우우미창찬공인류술(P<0.05).결론본결과제시,대우고혈압기저절구출혈,출혈량<50 ml적환자의선택미창찬공술치료,이대우출혈량≥50 ml적환자칙의선택소골창개로술치료.
Objective To compare the curative effect of micro-invasive drainage (MID) and small bone window craniotomy (SBWC) on hypertensive basal ganglia region hemorrhage (HBGRH). Methods Of 126 HBGRH patients with operative indication treated in our department, 67 had intracerebral hematomas <50 ml, and 59 ones ≥50 ml. Of 67 patients with hematomas >50 ml, 39 were treated by MID and 28 by SBWC. Of 59 patients with hematomas ≥50 ml, 25 were treated by MID, and 34 by SBWC. The curative effects were compared between the patients treated by different surgical methods. Results ①There is no significant difference in the total effective rates between the patients undergoing MID and ones undergoing SBWC (P>0.05). ②The effective rate was significantly higher in the patients with hematomas <50 ml undergoing MID than that in the patients with hemorrhage <50 ml undergoing SBWC (P<0.05). ③The effective rate was significantly lower in the patients with hematomas ≥50 ml undergoing MID than that in the patients with hematomas ≥50 ml undergoing SBWC (P<0.05). Conclusion It is suggested that the HBGRH patients with hematomas <50 ml should be treated by MID and the HBGRH ones with hematomas ≥50 ml should be treated by SBWC.